Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine

Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine

Radioiodine therapy of metastatic differentiated thyroid cancer is a highly effective method of treatment which makes it possible to achieve the complete cure of the majority of patients, however in some cases radioiodine refractory type develops, it leads to significant deterioration in overall and...

Full description

Bibliographic Details
Main Authors:	E. B. Vasil’eva, A. V. Vazhenin, T. M. Geliashvili, N. V. Fadeeva, A. V. Garev, A. O. Guz’
Format:	Article
Language:	Russian
Published:	ABV-press 2018-04-01
Series:	Opuholi Golovy i Šei
Subjects:	differentiated thyroid cancer radioiodine therapy sorafenib
Online Access:	https://ogsh.abvpress.ru/jour/article/view/320

Similar Items

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

Experience of sorafenib treatment in differentiated thyroid cancer from Taiwan
by: Chen-Yuan Lin, et al.
Published: (2021-01-01)

Selective use of sorafenib in the treatment of thyroid cancer
by: Pitoia F, et al.
Published: (2016-03-01)

Predictors of Response and Survival to Multikinase Inhibitors in Radioiodine Resistant Differentiated Thyroid Cancer
by: Tiziana Feola, et al.
Published: (2021-07-01)

The role of multikinase inhibitors target therapy in radioiodine-resistant differentiated thyroid cancer
by: P O Rumyantsev
Published: (2015-06-01)

The use of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in patients with differentiated thyroid cancer after initial treatment
by: T. M. Geliashvili, et al.
Published: (2017-04-01)

Radioiodine-resistant metastases of well-differentiated thyroid cancer, analysis of tumor characteristics and primary surgical intervention
by: M. V. Ostafiychuk, et al.
Published: (2021-10-01)

Papillary thyroid microcarcinoma
by: V A Smirnova, et al.
Published: (2015-06-01)

Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
by: Arwa Alsaud, et al.
Published: (2020-03-01)

A rare case of lingual thyroid with hyperthyroidism: A case report and review of the literature
by: Mattakarottu Joseph Jacob, et al.
Published: (2012-01-01)

Neoadjuvant target therapy of differentiated thyroid cancer (clinical observation)
by: P. A. Isaev, et al.
Published: (2017-04-01)

Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis
by: Yu S, et al.
Published: (2019-02-01)

Value of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in staging of patients with differentiated thyroid cancer after thyroidectomy during the first course of radioiodine therapy
by: T. M. Geliashvili, et al.
Published: (2021-01-01)

The diagnostic challenge of coexistent sarcoidosis and thyroid cancer – a retrospective study
by: Vera Wenter, et al.
Published: (2021-02-01)

Thyroid carcinoma in woman. gynecologist view
by: Т. Ф. Татарчук, et al.
Published: (2019-06-01)

Occurrence of symptomatic meningioma as a second neoplasm in patients with differentiated thyroid cancer treated with radioiodine
by: Nishikant Avinash Damle, et al.
Published: (2012-01-01)

Evaluation of Thyroid to Background Ratios in Hyperthyroid Cats
by: Bettencourt, Ann Elizabeth
Published: (2014)

Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases
by: Jochen Hammes, et al.
Published: (2018-12-01)

Sudden Development of Subcutaneous Nodules Shortly after Radioiodine Treatment for Thyroid Cancer Caused by Self-Limiting Sarcoidosis
by: Wael Zaher, et al.
Published: (2020-05-01)

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer
by: Lv RB, et al.
Published: (2017-08-01)

Recombinant human thyrotropin in radioiodine diagnostics and radioiodine ablation of patients with well-differentiated thyroid cancer: the first experience in Russia
by: Ivan I. Dedov, et al.
Published: (2018-12-01)

Follow-up of patients treated with retinoic acid for the control of radioiodine non-responsive advanced thyroid carcinoma
by: S.M. Coelho, et al.
Published: (2011-01-01)

Follow-up of patients treated with retinoic acid for the control of radioiodine non-responsive advanced thyroid carcinoma
by: S.M. Coelho, et al.
Published: (2011-01-01)

Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
by: M. S. Brose, et al.
Published: (2018-07-01)

Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
by: June-Key Chung, et al.
Published: (2014-09-01)

A rare case of laryngotracheal chondrosarcoma in a patient with past history of radioiodine therapy for thyroid cancer
by: Gholamreza Mohajeri, et al.
Published: (2013-01-01)

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy
by: Shirlei Kugler Aiçar Súss, et al.
Published: (2018-04-01)

A rare case of minimally invasive follicular thyroid cancer with intraluminal superior vena cava and right atrium metastases
by: Alex Cheen Hoe Khoo, et al.
Published: (2019-01-01)

Radioiodine-induced oxidative stress in patients with differentiated thyroid carcinoma and effect of supplementation with vitamins C and E and selenium (antioxidants)
by: Pedro Weslley Rosário, et al.
Published: (2016-02-01)

In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation
by: Luis Felipe Zavala, et al.
Published: (2019-04-01)

Restaging of differentiated thyroid carcinoma with SPECT/CT after radioiodine therapy
by: Mariya Alekseevna Karalkina, et al.
Published: (2015-07-01)

Partial response to sorafenib treatment associated with transient grade 3 thrombocytopenia in a patient with locally advanced thyroid cancer
by: Fabián Pitoia, et al.

Comparison of three methods used for measurement of radioiodine fixation in thyroid gland of mice
by: Jeremić Marija Ž., et al.
Published: (2013-01-01)

Case Report: Management of an Elderly Patient With Metastatic Radioiodine-Resistant Differentiated Thyroid Cancer in a Rural Community, Remote From Specialist Oncology Services
by: Rachael Wybrew, et al.
Published: (2021-02-01)

Algorithm of stepwise medical rehabilitation of patients with differentiated thyroid cancer
by: T. I. Grushina, et al.
Published: (2021-04-01)

Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation
by: E. V. Borodavina, et al.
Published: (2020-04-01)

Original paper<br>Effects of absorbed dose of 131I isotope on the effectiveness of ablation of thyroid remnant tissue
by: Zbigniew Adamczewski, et al.
Published: (2007-06-01)

Ultrasound Assessment of Autonomous Thyroid Nodules before and after Radioiodine Therapy Using Thyroid Imaging Reporting and Data System (TIRADS)
by: Simone Agnes Schenke, et al.
Published: (2020-12-01)

RADIOIODINE THERAPY OF PAPILLARY THYROID CANCER, COMPLICATED BY A RADIAL MYELITIS. CLINICAL CASE
by: L. M. Farkhutdinova
Published: (2018-06-01)

Influence of recombinant human thyroid-stimulating hormone of and radioiodine therapy on the function of cells of innate immunity in patients with thyroid cancer
by: T.F. Zakharchenko, et al.
Published: (2018-09-01)

Cannot write session to /tmp/vufind_sessions/sess_c1q0d37buhdonsgp4npp8hvfjg